Filter by

  • AHEAD 3-45 Study

    Diagnosis Requirements: None
    Age Eligibility: 55 to 80 years
    Medication: Lecanemab or placebo

    This study reviews a new treatment to prevent memory decline and slow the earliest symptoms of Alzheimer’s disease.

  • mother and daughter

    Heart Function and Brain Health Study

    Diagnosis Requirements: Normal Heart Function or Diastolic Dysfunction
    Age Eligibility: 60 years or older

    The purpose of this clinical trial is to study heart function in relation to brain health.

  • DiverseVCID: Diverse Vascular Contributions to Cognitive Impairment and Dementia

    Diagnosis Requirements: None
    Age Eligibility: 65 to 90 years
    Medication: None

    The results of this study will be used to develop and validate a predictive risk model to inform future care.